Nyumbani › Scleroderma › Illinois › Chicago
Majaribio ya kliniki ya Scleroderma katika Chicago, IL
Masomo 10 ya Scleroderma yanatafuta washiriki katika vituo vya Chicago na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
InaajiriHatua 3
- Northwestern University, Chicago
- The University of Chicago Medical Center, Chicago
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
InaajiriHatua 2
- University of Illinois Health Outpatient Care Center, Chicago
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
InaajiriHatua 1
- The University of Chicago Medical Center, Chicago
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
InaajiriHatua 2/3
- GSK Investigational Site, Chicago
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
InaajiriHatua 1
- Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Platform Clinical Study for Conquering Scleroderma
InaajiriHatua 2
- The University of Chicago Medical Center (UCMC), Chicago
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
InaajiriHatua 2/3
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
InaajiriHatua 1/2
- Nkarta Investigational Site, Chicago
A Study of AZD0120 in Autoimmune Diseases
InaajiriHatua 1
- Research Site, Chicago
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
InaajiriHatua 2
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
Majaribio ya Scleroderma katika miji mingine
- New York City, NYUtafiti 11
- Ann Arbor, MIUtafiti 10
- Houston, TXUtafiti 9
- Boston, MAUtafiti 7
- Durham, NCUtafiti 7
- Los Angeles, CAUtafiti 7
- New Orleans, LAUtafiti 6
- Baltimore, MDUtafiti 6
- Philadelphia, PAUtafiti 6
- Dallas, TXUtafiti 5
- Pittsburgh, PAUtafiti 5
- Plantation, FLUtafiti 4
Masomo mengine katika Chicago
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 61
- Saratani ya MatitiUtafiti 58
- Saratani (aina zote)Utafiti 51
- Saratani ya MetastasiUtafiti 45
- Saratani ya ProstateUtafiti 45
- UnenepuUtafiti 41
- Saratan ya MapafuUtafiti 41
- Kansari ya MayaiUtafiti 36
- KigonjwaUtafiti 34
- Kansari ya kolorektaliUtafiti 33
- Kushindwa kwa MoyoUtafiti 31
- Uzito Kupita KiasiUtafiti 28
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.